HomeRGEN • NASDAQ
add
Repligen Corp
$142.58
Makalipas ang Oras ng Trabaho:(0.00%)0.00
$142.58
Sarado: Nob 22, 4:05:02 PM GMT-5 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$141.76
Sakop ng araw
$140.59 - $145.21
Sakop ng taon
$113.50 - $211.13
Market cap
7.99B USD
Average na Volume
687.92K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 154.87M | 9.69% |
Gastos sa pagpapatakbo | 83.65M | 28.98% |
Net na kita | -654.00K | -103.86% |
Net profit margin | -0.42 | -103.50% |
Kita sa bawat share | 0.43 | 86.96% |
EBITDA | 12.72M | 22.14% |
Aktuwal na % ng binabayarang buwis | 43.08% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 783.96M | 24.29% |
Kabuuang asset | 2.83B | 12.59% |
Kabuuang sagutin | 813.96M | 54.87% |
Kabuuang equity | 2.02B | — |
Natitirang share | 56.03M | — |
Presyo para makapag-book | 3.94 | — |
Return on assets | -0.41% | — |
Return on capital | -0.43% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -654.00K | -103.86% |
Cash mula sa mga operasyon | 49.32M | 25.72% |
Cash mula sa pag-invest | -5.86M | 33.19% |
Cash mula sa financing | -69.60M | -8,846.53% |
Net change in cash | -25.18M | -192.84% |
Malayang cash flow | 37.87M | -23.71% |
Tungkol
Repligen Corporation is an American company devoted to the development and production of materials used in the manufacture of biological drugs. The company is based in Waltham, Massachusetts, and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. In February 2014, Repligen had employed 116 people, about 50% of these based in Sweden. Wikipedia
CEO
Itinatag
1981
Headquarters
Website
Mga Empleyado
1,783
